Machine Learning Algorithm to Predict Obstructive Coronary Artery Disease: Insights from the CorLipid Trial
Authors:
- Eleftherios PanterisEleftherios Panteris
- Olga DedaOlga Deda
- Andreas S. PapazoglouAPAndreas S. Papazoglou
- Efstratios KaragiannidisEKEfstratios Karagiannidis
- Theodoros LiapikosTLTheodoros Liapikos
- Olga BegouOlga Begou
- Thomas MeikopoulosTMThomas Meikopoulos
- Thomai MouskeftaraTMThomai Mouskeftara
- Georgios SofidisGSGeorgios Sofidis
- Georgios SianosGSGeorgios Sianos
- Georgios TheodoridisGeorgios Theodoridis
- Helen GikaHelen Gika
Open Access
- 30 August 2022
- journal article
- research article
- Published by MDPI AG in Metabolites
- Vol. 12 (9) , 816
Abstract
Developing risk assessment tools for CAD prediction remains challenging nowadays. We developed an ML predictive algorithm based on metabolic and clinical data for determining the severity of CAD, as assessed via the SYNTAX score. Analytical methods were developed to determine serum blood levels of specific ceramides, acyl-carnitines, fatty acids, and proteins such as galectin-3, adiponectin, and APOB/APOA1 ratio. Patients were grouped into: obstructive CAD (SS > 0) and non-obstructive CAD (SS = 0). A risk prediction algorithm (boosted ensemble algorithm XGBoost) was developed by combining clinical characteristics with established and novel biomarkers to identify patients at high risk for complex CAD. The study population comprised 958 patients (CorLipid trial (NCT04580173)), with no prior CAD, who underwent coronary angiography. Of them, 533 (55.6%) suffered ACS, 170 (17.7%) presented with NSTEMI, 222 (23.2%) with STEMI, and 141 (14.7%) with unstable angina. Of the total sample, 681 (71%) had obstructive CAD. The algorithm dataset was 73 biochemical parameters and metabolic biomarkers as well as anthropometric and medical history variables. The performance of the XGBoost algorithm had an AUC value of 0.725 (95% CI: 0.691–0.759). Thus, a ML model incorporating clinical features in addition to certain metabolic features can estimate the pre-test likelihood of obstructive CAD.Keywords
Funding Information
- European Regional Development Fund of the European Union and Greek national funds (T1EDK-04005)
This publication has 49 references indexed in Scilit:
- Integration of metabolomics, lipidomics and clinical data using a machine learning methodBMC Bioinformatics, 2016
- XGBoost2016
- Moving beyond regression techniques in cardiovascular risk prediction: applying machine learning to address analytic challengesEuropean Heart Journal, 2016
- Review and evaluation of penalised regression methods for risk prediction in low‐dimensional data with few eventsStatistics in Medicine, 2015
- Metabolomics as a tool for cardiac researchNature Reviews Cardiology, 2011
- Validation of the Global Registry of Acute Coronary Event (GRACE) risk score for in-hospital mortality in patients with acute coronary syndrome in CanadaAmerican Heart Journal, 2009
- Beyond Established and Novel Risk FactorsCirculation, 2008
- The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease.2005
- A Decision-Theoretic Generalization of On-Line Learning and an Application to BoostingJournal of Computer and System Sciences, 1997
- Analysis of Probability as an Aid in the Clinical Diagnosis of Coronary-Artery DiseaseNew England Journal of Medicine, 1979